Skip to content

Antidepressant Efficacy of Prefrontal Transcranial Magnetic Stimulation Monotherapy in Non-drug-responsive Major Depression: a Randomized Case-control Study

Antidepressant Efficacy of Prefrontal Transcranial Magnetic Stimulation Monotherapy in Non-drug-responsive Major Depression: a Randomized Case-control Study - Direct comparisons of antidepressant effects between rTMS and iTBS

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000020892
Enrollment
120
Registered
2016-02-04
Start date
2016-02-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

A treatment option for Medication-resistant depression

Interventions

Left DLPFC intermittent TBS group (1 session/day, 5 days/week,2weeks)
80% active motor threshold, 1800 pulses once Left DLPFC 10Hz rTMS group (1 session/day, 5 days/week,2weeks)
100% motor threshold,1600 pulses once Sham group(1 session/day, 5 days/week,2weeks) randomly divided to half with TBS and half with rTMS parameters using a sham coil.

Sponsors

Taipei Veterans General Hospital, Taiwan
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: adult patients with the relapse of major depressive episode

Exclusion criteria

Exclusion criteria: Patients with schizophrenia, organic mental disorder and major physical illness; with brain implants or cardiac pacemakers; pregnancy; or who having strong suicidal risk

Design outcomes

Primary

MeasureTime frame
the changing of HDRS-17 (week-2 vs. baseline) in response to the 2-week prefrontal brain stimulation

Secondary

MeasureTime frame
Computerized rACC-engaging cognitive tasj(RECT); EEG; Maudsley Staging method for refractoriness; response rate; the changing of HDRS-17 of the 12-week follow-up after the treatment (week-14 vs. baseline) in response to the 2-week brain stimulation; Young mania Rating scale; Clinical Global Index; Depression and somatic symptoms; Life stress scale; the comparison for localization between" 5 cm rule" and MRI neuro-navigation.

Countries

Asia(except Japan)

Contacts

Public ContactCheng-Ta Li

Taipei Veterans General Hospital, Taiwan Psychiatry

on5083@msn.com+88628757027

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026